{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-019906","form_type":"8-K","ticker":"APRE","cik":"0001781983","company_name":"Aprea Therapeutics, Inc.","filed_at":"2023-02-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.517651+00:00","generated_at":"2026-06-19T14:17:24.212465+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Aprea Therapeutics completes 1-for-20 reverse stock split; Nasdaq halt through Feb 14","bullets":["Reverse stock split 1-for-20 effective 5:00 p.m. ET on Feb 10, 2023.","Nasdaq halted trading in APRE at 7:50 p.m. Feb 10 pending material news related to split.","Halt is administrative; trading expected to resume at 9:45 a.m. on Feb 14, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-019906","json":"https://secwatch.observer/filing/0001104659-23-019906.json","markdown":"https://secwatch.observer/filing/0001104659-23-019906.md","text":"https://secwatch.observer/filing/0001104659-23-019906.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1781983/000110465923019906/0001104659-23-019906-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1781983/000110465923019906/tm236659d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T14:17:24.212465+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}